SCHEMBL4730620

SCHEMBL4730620

CNC(=O)c1cnccc1I

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NUDT1 P36639 1/20 0.46
KDM4C Q9H3R0 2/20 0.43
MKNK1 Q9BUB5 1/20 0.42
MKNK2 Q9HBH9 1/20 0.42
CASP1 P29466 1/20 0.42
SIRT3 Q9NTG7 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
KDM5A P29375 1/20 0.40
ROCK2 O75116 1/20 0.40
ROCK1 Q13464 1/20 0.40
GAA P10253 2/20 0.39
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
GLA P06280 1/20 0.39
PKN1 Q16512 1/20 0.38
PKN2 Q16513 1/20 0.38
CCNC P24863 1/20 0.38
CDK8 P49336 1/20 0.38
HPGD P15428 1/20 0.38
KDM4D Q6B0I6 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6869843 0.87 KDM4C (0.49) NUDT1KDM4CMKNK1MKNK2CASP1
SCHEMBL15549183 0.81 ROCK2 (0.40) NUDT1KDM4CSIRT3TDP1ROCK2
SCHEMBL30107188 0.79 SIRT3 (0.61) NUDT1KDM4CMKNK1MKNK2CASP1
SCHEMBL13162016 0.79 SIRT3 (0.61) NUDT1KDM4CMKNK1MKNK2CASP1
SCHEMBL16676647 0.79 KDM4C (0.58) NUDT1KDM4CMKNK1MKNK2CASP1
SCHEMBL31678780 0.79 KDM4C (0.58) NUDT1KDM4CMKNK1MKNK2CASP1
SCHEMBL5700319 0.79 TDP1 (0.46) KDM4CSIRT3TDP1ROCK2ROCK1
SCHEMBL19439267 0.78 KDM4C (0.61) NUDT1KDM4CMKNK1MKNK2TDP1
SCHEMBL1232259 0.78 GAA (0.50) NUDT1KDM4CMKNK1MKNK2CASP1
SCHEMBL1507133 0.78 ROCK2 (0.65) NUDT1KDM4CMKNK1MKNK2CASP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110112110-A1 ANTIPROLIFERATIVE COMPOUNDS AND THERAPEUTIC USES THEREOF UNIVERSITA' DEGLISTUDI DI MILANO- BICOCCA (IT) 2011-05-12 US disclosed
US-20110112110-A1 ANTIPROLIFERATIVE COMPOUNDS AND THERAPEUTIC USES THEREOF UNIVERSITA' DEGLISTUDI DI MILANO- BICOCCA (IT) 2011-05-12 US disclosed
WO-2008044099-A1 CHARGE TRANSFER COMPLEXES IN THE TREATMENT OF INFLAMMATORY BOWEL DISEASES GHISALBERTI CARLO (BR) 2008-04-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110112110-A1 ANTIPROLIFERATIVE COMPOUNDS AND THERAPEUTIC USES THEREOF ABL1, MKI67, BCR NUDT1 976/4885KDM4C 3014/4885MKNK1 440/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.